Current and Emerging Systemic Treatment Strategies for Psoriasis
Authors:
- 1 October 2012
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 72 (14) , 1867-1880
Abstract
Psoriasis is a common chronic inflammatory disease of the skin that has a significant impact on quality of life. A small number of systemic therapies are well established in psoriasis management....Keywords
This publication has 111 references indexed in Scilit:
- Activation of Protein Kinase C Isoforms and Its Impact on Diabetic ComplicationsCirculation Research, 2010
- Comparison of Ustekinumab and Etanercept for Moderate-to-Severe PsoriasisNew England Journal of Medicine, 2010
- British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009British Journal of Dermatology, 2009
- PsoriasisNew England Journal of Medicine, 2009
- The alliance of sphingosine-1-phosphate and its receptors in immunityNature Reviews Immunology, 2008
- Therapeutic targeting of Janus kinasesImmunological Reviews, 2008
- T-Helper 17 Cells in Psoriatic Plaques and Additional Genetic Links between IL-23 and PsoriasisJournal of Investigative Dermatology, 2008
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)The Lancet, 2008
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)The Lancet, 2008
- German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)Archives of Dermatological Research, 2007